Narayana Hrudayalaya Ltd announces financial results for Q4, FY2020

Narayana Hrudayalaya Limited, a leading healthcare service provider in India, today announced its financial results for the fourth quarter (Q4 FY20) ended March 31st, 2020.

Financial Highlights for the Quarter (Q4 FY20) Prepared in accordance with Ind AS ('Indian Accounting Standards')

- Consolidated total operating income was Rs 7,429 mn for Q4 FY20 as compared to Rs 7,652 mn in the corresponding period of the previous year, reflecting a decrease of 2.9%

- Consolidated EBITDA* stood at Rs 1,028 mn, reflecting a margin of 13.8% as against Rs 968 mn in Q4 FY19, translating into a YoY growth of 6.2%

Financial Highlights for the Twelve Months (12M FY20)

- Consolidated total operating income was Rs 31,278 mn for 12M FY20 as compared to Rs 28,609 mn in the corresponding period of the previous year reflecting an increase of 9.3%

- Consolidated EBITDA* stood at Rs 4,467 mn, reflecting a margin of 14.3% as against Rs 3,045 mn in 12M FY19, translating into a YoY growth of 46.7%

-Consolidated PAT* stood at Rs 1,191 mn, reflecting a margin of 3.8% as against Rs 593 mn in 12M FY19, translating into a YoY growth of 100.8%

* This is as per the new accounting treatment for leases per IND AS 116 effective 1st April which resulted in Rs 183 mn increase in EBITDA and decrease of Rs 75 mn in PAT for Q4 FY 20 and Rs 408 mn increase in EBITDA and decrease of Rs 209 mn in PAT for 12M FY 20 on a like-to-like basis (pre-IND AS 116)

As on March 31st, 2020, the consolidated net debt was Rs 6,031 mn representing a net debt to equity ratio of 0.53. (Out of which, debt worth US$ 47.8 mn is foreign currency denominated).

Other Highlights during the Quarter

- Narayana Superspeciality Hospital, Gurugram successfully operated a very rare case of adenoid cystic carcinoma of trachea which has a typical incidence of 1-2 per million of population

- Narayana Institute of Cardiac Sciences, Bengaluru successfully performed a heart transplant on a 4-year-old patient, the youngest patient in the state to have undergone a heart transplant till date

- Narayana Superspeciality Hospital, Howrah successfully treated a rare case of a baby suffering from ALCAPA (Anomalous Left Coronary Artery arising from Pulmonary Artery)

- Narayana Superspeciality Hospital, Gurugram successfully performed endovascular procedure of dural fistula embolization patient diagnosed with complex torcular dural fistula with severe intracranial venous hypertension

Commenting on the performance, Dr. Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said "Having generated strong momentum over the last few quarters, we are pleased to end fiscal year 2020 with significant growth in the operating EBITDA along with healthy return ratios amidst the outbreak of Covid-19 virus which affected the business in the later part of fourth quarter. It is heartening to highlight that we have been able to achieve this on the back of all-round growth registered by hospitals across the network in India as well as our overseas operations at Cayman Islands.

In the backdrop of the unprecedented crisis the world is facing at the moment, there is no denying the short-term challenges for our industry. With strategic focus on consolidation of operations strengthening our Balance Sheet, we remain optimistic about our business prospects in the medium term. Centered around our unflinching commitment towards ensuring safety for our patients and staff at all times, we remain confident in our ability to deliver quality care during these testing times."

Shares of Narayana Hrudayalaya Ltd was last trading in BSE at Rs.294 as compared to the previous close of Rs. 286.05. The total number of shares traded during the day was 4890 in over 492 trades.

The stock hit an intraday high of Rs. 298.95 and intraday low of 286.35. The net turnover during the day was Rs. 1430050.

Source : Equity Bulls

Keywords